Jonathan Hepple
InvestorManaging Partner at Rosetta Capital Ltd.
About
Jon Hepple is a co-founder of Rosetta Capital with over 20 years of investment experience in life sciences. He began his investment career at Rothschild Asset Management and was later a partner at Seroba Life Sciences, where he held board seats at Covagen and Opsona. He is a Senior Advisor to Oxford Science Enterprises and holds a PhD from Cambridge University.
Invests in
Biotech
Investments
Board seats
Aprea TherapeuticsCarrick TherapeuticsCatalyst BiosciencesCovagenGlycoMimeticsMission TherapeuticsNovimmuneNucleome TherapeuticsOpsonaParatekTranzyme
Per the firm's website.
Colleagues at Rosetta Capital Ltd.
Donovan Leung
Investment Manager at Rosetta Capital Ltd.
Graham Fagg
Partner Emeritus at Rosetta Capital Ltd.
Ken Macleod
Partner at Rosetta Capital Ltd.
Matthew James
Chief Financial Officer at Rosetta Capital Ltd.
Michael Forer
Partner at Rosetta Capital Ltd.
Namrata Turaga
Investment Manager at Rosetta Capital Ltd.